5-Aza-2'-deoxycytidine, Spleen, Antibody Formation 5-Aza-2'-deoxycytidine which is preferentially taken up by the lymphatic tissue and is in corporated into D NA strongly affects the ability of the immune system to synthesize IgG anti bodies against sheep red blood cells without affecting IgM antibody formation. A single dose of the drug results in a prolonged inhibition persisting 14 days after the secondary immunization. The inhibitory effect is dose-dependent and is maximal when 5-aza-2'-deoxycytidine is given 2 days after sheep erythrocytes. The drug affects the utilization o f thymidine for the synthesis of DNA in the spleen; under certain conditions the enhancement of the rate o f DNA synthesis in the spleen has been observed. 5-Aza-2'-deoxycytidine has a considerable cyto static activity suppressing the cell growth in AKR mice with lym phatic leukem ia, in P 388 leukemia bearing mice, and in L 1210 leukem ia [1] [2] [3] . The drug is generally incorporated into rapidly proliferating cells and its uptake into lymphatic sys tem is preferential [4, 5] .
5-Aza-2'-deoxycytidine has a considerable cyto static activity suppressing the cell growth in AKR mice with lym phatic leukem ia, in P 388 leukemia bearing mice, and in L 1210 leukem ia [1] [2] [3] . The drug is generally incorporated into rapidly proliferating cells and its uptake into lymphatic sys tem is preferential [4, 5] .
Recently a m odulatory effect o f 5-azacytidine on antibody production in rats immunized with sheep red blood cells (SRBC) was observed [6] . Although the mode of action o f 5-azacytidine differs from that of its 2'-deoxy derivative [5] , we undertook in this study to follow the effect of 5-aza-2'-deoxycytidine on the immune response of rats immunized before or after the adm inistration of the drug. Simultane ously the changes in the rate of DNA synthesis in the spleen were measured. 
Materials and Methods

Reagents
Animals, immunization and antibody assay
In all experiments W istar albino female rats kept under standard laboratory conditions were used. Both the drug and a 30% suspension of 3 times washed SRBC were injected IP. The tim e interval between prim ary and secondary im m unization was 28 days. The blood samples were collected by cardial puncture. The haem agglutinin titres were measured using Takatsy m icrotitrator and are expressed as -log2 of the highest dilution in which the haemagglutination was still observed. The level of IgG anti bodies was determ ined after the treatm ent of sera with an equal volume of 0.2 m 2-m ercaptoethanol. The data were subjected to analysis o f variance and the significance of differences was determ ined using Duncan test.
Incorporation o f thymidine into DNA
[2-14C]Thymidine (2-4 |iC i per 0.05-0.1 ^mol per animal) was injected IP to groups of 4 -6 female rats 2 h before killing. The excised tissues were cooled and im m ediately homogenized in 2 volumes of water. 3 ml of the homogenates were mixed with 3 ml of 0.4 m HC104 , centrifuged, and repeatedly washed with 0.2 M HC104 . F urther pro cedure and hydrolysis of DN A were carried out as described earlier [7] , Spectroscopically pure [2-14C]-thymine was estim ated with a spectrophotom eter Unicam SP 700; the radioactivity was assayed in a Packard liquid scintillation spectrometer. The rate of [2-14C] thymidine incorporation was expressed as the specific radioactivity o f [2-14C] thymine isolated from the total tissues DNA (dpm/^imol).
Tissue distribution an d incorporation o f p*H] 5-aza-2'-deoxycytidine
Tritiated drug (400 pCi/0.02 (imol per anim al) was injected IP to groups o f 4 female rats (180 g). The animals were killed at different tim e intervals thereafter by cervical dislocation and bled. The tissues under investigation were removed and ho mogenized in a cooled glass hom ogenizer with a tight-fitting Teflon pestle in 10 volumes o f cold 0.25 m M KC1. One-ml portions of the homogenates were mixed with 1 ml o f 0.4 M HC104 , the suspen sions centrifuged (5 0 0 0 x # , 5 min, 2°C ) and sedi ments 3 times extracted with cold 0.2 M H C 104 to remove the acid soluble low-m olecular-weight com ponents. Resulting sediments were extracted at 37 °C with 5 ml of alcohol-ether (3 : 1), dried and dissolved at 80° C in 1 ml o f conc. formic acid. The radio activity of aliquots and absorbance at 260 nm were measured using liquid scintillation system Isocap/ 300 (Nuclear Chicago Division) and spectrophotom eter Unicam SP 700, respectively.
Results
5
-Aza-2'-deoxycytidine adm inistered IP to rats is readily distributed among various tissues. W hile the highest level o f the radioactivity in the acid-soluble low-molecular-weight pool was found (Table I) in the liver, much lower am ounts were present in the kidney, the spleen and in the thymus. However, Table I measurements of the radioactivity in the acid-in soluble fraction of the cells revealed different pic ture. The highest amounts of the drug were incorpo rated into high-molecular-weight fraction in the spleen and in the thymus ( Fig. 1 ), while the lowest radioactivity was found in the liver nucleic acids. The chemical and autoradiographic analyses o f the radioactivity incorporated into polymer indicated the incorporation o f 5-aza-2'-deoxycytidine into DN A [1] . The preferential uptake o f 5-aza-2'-deoxycytidine by the lym phatic tissues and the incorporation of the drug into DN A led us to follow its effect on the synthesis o f antibodies stim ulated by sheep red blood cells. The results obtained (Fig. 2) indicate a pronounced inhibitory action of 5-aza-2'-deoxycytidine on the form ation of IgG antibodies. The m axi mal effect was observed when the analogue was adm inistered 2 days following immunization. The decline in IgG antibody titres was long-lasting and was observed also after the secondary and tertiary im m unization (Table II) .
The degree o f the inhibitory action of 5-aza-2'-deoxycytidine on the synthesis o f IgG antibodies in relation to dose level of the drug is apparent from Fig. 3 . The m inim al dose of 5-aza-2/-deoxycytidine required to inhibit the synthesis of IgG antibodies significantly (Fig. 3B ) was 0 .2 -0 .6 mg/kg. There was a slight but significant enhancement of IgM antibody production when the drug was applied si multaneously with the antigen (Fig. 3 A) .
F urther we followed the changes in the synthesis of DN A in the spleen and the thymus of 5-aza-2'-deoxycytidine treated rats im m unized at different time intervals with SRBC. The data summarized in Table III indicate that the rate o f DNA synthesis in the spleen and the thymus is not significantly altered during immunization. However, the adm inistration of 5-aza-2'-deoxycytidine simultaneously or shortly after sheep erythrocytes resulted in a marked and reproducible increase of the rate of DNA synthesis 28 days after the drug treatment. The adm inistration o f the aza analogue 2 days after imm unization, at a m om ent when the drug-mediated inhibition of IgG antibody synthesis was maximal, had a much lower stimulatory effect on DNA synthesis. 5-Aza-2'-deoxycytidine administered alone caused both the depression and enhancement of thym idine incorporation into DNA in the spleen (Fig. 4) . Short ly after the IP injection of the drug the rate of DNA synthesis is depressed more than 50 per cent and thereafter, beginning with the third day, gradually increases. The highest stimulation of thym idine in corporation into spleen DNA was observed in ani mals pretreated with 5-aza-2/-deoxycytidine 8 -14 days before immunization.
Discussion
In the majority of the studies on the im m unosup pressive effects of different cytostatics the authors have used repeated administrations at high doses while following the survival of skin grafts or early prim ary antibody response [8] [9] [10] [11] . In our ex periments a single dose of 5-aza-2'-deoxycytidine led im m ediately to an abrogation of IgG antibody pro duction and to a decrease of IgM titres when given 2 days after immunization. Nevertheless, while the IgM antibody titres were quickly restored to normal levels, the production of IgG antibodies remained low for the 12-week period of observation notw ith standing the secondary and tertiary im m unization w ithout the additional drug administration.
The rem arkable immunosuppressive action of 5-aza-2'-deoxycytidine seems to be related to its selec tive affinity to the lymphatic system [5] , and could be at least partially mediated by its cytotoxic effect against antibody-forming cells, as has been shown for cyclophosphamide [12] or azathioprine [13] . How ever, the direct cytotoxic effect could have hardly caused the profound and long-lasting decrease of IgG antibody production as observed in our experi ments, especially in view to the short half-tim e of 5-aza-2'-deoxycytidine in blood circulation (4 h). It is likely that the drug affects preferentially specific populations of regulatory T lymphocytes. This pre sum ption is supported by the finding that another nucleoside analogue, azathioprine, exerts selective affinity to long-lived T cells [14] .
5-Azacytidine has also a considerable influence upon the immune response of rats to SRBC [6] . However, there is a rem arkable difference between the two drugs: While 5-azacytidine considerably in-creased IgG antibody production when given sim ul taneously with antigen, much lower enhancing ac tivity could be dem onstrated with the deoxy deriva tive. Using various doses o f 5-aza-2'-deoxycytidine a small increase of IgG titres was observed only ex ceptionally. On the other hand, 5-aza-2'-deoxycytidine exerts much stronger immunosuppressive effect in comparison with 5-azacytidine when given 2 days after the antigen.
The underlying mechanism of 5-aza-2'-deoxycytidine action on the synthesis of DN A in lym phatic tissues is not yet known [15] . The analogue is pref erentially incorporated into DNA of the spleen and thymus (Fig. 1 ) resulting initially in a decreased and later on in an increased rate of thym idine incorpora tion into spleen DN A (Fig. 4) . The im m unization of animals with SRBC simultaneously or 2 days before the adm inistration o f 5-aza-2'-deoxycytidine (Table  III) induced a significant enhancement of thym idine uptake into DNA both in the spleen and in the thymus of the treated animals. Im m unization alone caused only slight and non-significant increase of thym idine incorporation into DNA measured 4 weeks later.
While 5-aza-2'-deoxycytidine adm inistration leads to a marked depression of thym idine and thymidylate kinase activities in the spleen and thymus of rats and mice [15] paralleled by the lower incorpora tion of thym idine into DNA, no inhibitory effect of the analogue was found in regenerating rat livers highly sensitive to the action of 5-azacytidine [7] , It is known [16] that the activity of deoxycytidine kinase is high in the lym phatic tissues and low in the liver; for this reason 5-aza-2'-deoxycytidine is more easily metabolized to higher 5'-phosphates by lym phoid cells than by hepatocytes and consequently it has no effect on liver regeneration. The differences in the levels o f deoxycytidine kinase in m am m alian tissues seem to be responsible for the selective uptake of the drug by the lym phatic system.
